22nd Century Group Inc (XXII)

$0.09

Market is closed - opens 8 PM, 25 Nov 2024

Performance

  • $0.09
    $0.10
    $0.09
    downward going graph

    0.0%

    Downside

    Day's Volatility :5.36%

    Upside

    5.36%

    downward going graph
  • $0.08
    $5.28
    $0.09
    downward going graph

    8.0%

    Downside

    52 Weeks Volatility :98.43%

    Upside

    98.3%

    downward going graph

Returns

Period22nd Century Group IncSector (Consumer Staples)Index (Russel 2000)
3 Months
-81.44%
0.0%
0.0%
6 Months
-92.47%
6.4%
0.0%
1 Year
-97.39%
16.7%
0.0%
3 Years
-99.99%
12.0%
-24.0%

Highlights

Market Capitalization
4.6M
Book Value
$0.26
Earnings Per Share (EPS)
-17.92
PEG Ratio
0.0
Wall Street Target Price
720.0
Profit Margin
0.0%
Operating Margin TTM
-56.79%
Return On Assets TTM
-23.33%
Return On Equity TTM
36.28%
Revenue TTM
9.9M
Revenue Per Share TTM
1.46
Quarterly Revenue Growth YOY
-61.0%
Gross Profit TTM
-3.1M
EBITDA
-18.0M
Diluted Eps TTM
-17.92
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Sell
    0
    0%Buy
    50%Hold
    50%Sell
Based on 6 Wall street analysts offering stock ratings for 22nd Century Group Inc(by analysts ranked 0 to 5 stars)
Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
00
6
7
Hold
3
2
2
Sell
3
00
00

Analyst Forecast

What analysts predicted

Upside of 799900.0%

Current $0.09
Target $720.00

Company Financials

FY18Y/Y Change
Revenue
26.4M
↑ 59.19%
Net Income
-8.0M
↓ 38.85%
Net Profit Margin
-30.15%
↑ 48.34%
FY19Y/Y Change
Revenue
25.8M
↓ 2.25%
Net Income
-24.2M
↑ 203.7%
Net Profit Margin
-93.66%
↓ 63.51%
FY20Y/Y Change
Revenue
28.1M
↑ 8.82%
Net Income
-19.7M
↓ 18.53%
Net Profit Margin
-70.12%
↑ 23.54%
FY21Y/Y Change
Revenue
30.9M
↑ 10.09%
Net Income
-32.6M
↑ 65.44%
Net Profit Margin
-105.37%
↓ 35.25%
FY22Y/Y Change
Revenue
62.1M
↑ 100.69%
Net Income
-59.8M
↑ 83.39%
Net Profit Margin
-96.28%
↑ 9.09%
FY23Y/Y Change
Revenue
32.2M
↓ 48.15%
Net Income
-140.8M
↑ 135.41%
Net Profit Margin
-437.14%
↓ 340.86%
Q2 FY23Q/Q Change
Revenue
23.4M
↑ 6.67%
Net Income
-20.5M
↑ 20.77%
Net Profit Margin
-87.67%
↓ 10.23%
Q3 FY23Q/Q Change
Revenue
7.9M
↓ 66.4%
Net Income
-72.7M
↑ 254.06%
Net Profit Margin
-923.9%
↓ 836.23%
Q4 FY23Q/Q Change
Revenue
7.4M
↓ 6.53%
Net Income
-29.3M
↓ 59.66%
Net Profit Margin
-398.7%
↑ 525.2%
Q1 FY24Q/Q Change
Revenue
6.5M
↓ 12.07%
Net Income
-5.7M
↓ 80.43%
Net Profit Margin
-88.72%
↑ 309.98%
Q2 FY24Q/Q Change
Revenue
7.9M
↑ 22.85%
Net Income
-1.1M
↓ 80.62%
Net Profit Margin
-13.99%
↑ 74.73%
Q3 FY24Q/Q Change
Revenue
5.9M
↓ 25.18%
Net Income
-3.8M
↑ 237.86%
Net Profit Margin
-63.19%
↓ 49.2%
FY18Y/Y Change
Total Assets
77.3M
↓ 3.06%
Total Liabilities
6.0M
↑ 39.61%
FY19Y/Y Change
Total Assets
69.0M
↓ 10.8%
Total Liabilities
6.9M
↑ 14.59%
FY20Y/Y Change
Total Assets
51.7M
↓ 25.03%
Total Liabilities
7.6M
↑ 9.9%
FY21Y/Y Change
Total Assets
76.0M
↑ 46.93%
Total Liabilities
9.9M
↑ 30.27%
FY22Y/Y Change
Total Assets
114.7M
↑ 50.95%
Total Liabilities
18.7M
↑ 89.03%
FY23Y/Y Change
Total Assets
27.5M
↓ 76.01%
Total Liabilities
35.9M
↑ 92.29%
Q2 FY23Q/Q Change
Total Assets
125.0M
↑ 0.68%
Total Liabilities
52.4M
↑ 22.46%
Q3 FY23Q/Q Change
Total Assets
64.2M
↓ 48.63%
Total Liabilities
50.4M
↓ 3.79%
Q4 FY23Q/Q Change
Total Assets
27.5M
↓ 57.16%
Total Liabilities
35.9M
↓ 28.75%
Q1 FY24Q/Q Change
Total Assets
24.6M
↓ 10.5%
Total Liabilities
36.2M
↑ 0.91%
Q2 FY24Q/Q Change
Total Assets
24.1M
↓ 2.14%
Total Liabilities
25.0M
↓ 30.89%
Q3 FY24Q/Q Change
Total Assets
26.2M
↑ 8.67%
Total Liabilities
22.7M
↓ 9.34%
FY18Y/Y Change
Operating Cash Flow
-17.8M
↑ 47.86%
Investing Cash Flow
15.1M
↓ 125.0%
Financing Cash Flow
-355.4K
↓ 100.57%
FY19Y/Y Change
Operating Cash Flow
-14.6M
↓ 18.25%
Investing Cash Flow
4.6M
↓ 69.94%
Financing Cash Flow
9.9M
↓ 2890.09%
FY20Y/Y Change
Operating Cash Flow
-15.6M
↑ 7.09%
Investing Cash Flow
16.5M
↑ 261.8%
Financing Cash Flow
-304.0K
↓ 103.07%
FY21Y/Y Change
Operating Cash Flow
-22.8M
↑ 46.21%
Investing Cash Flow
-27.7M
↓ 268.37%
Financing Cash Flow
50.9M
↓ 16835.2%
FY22Y/Y Change
Operating Cash Flow
-51.7M
↑ 126.43%
Investing Cash Flow
22.6M
↓ 181.42%
Financing Cash Flow
30.8M
↓ 39.42%
Q2 FY23Q/Q Change
Operating Cash Flow
-19.8M
↑ 126.65%
Investing Cash Flow
4.2M
↓ 71.47%
Financing Cash Flow
9.1M
↓ 49.95%

Technicals Summary

Sell

Neutral

Buy

22nd Century Group Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
22nd Century Group Inc
22nd Century Group Inc
-22.87%
-92.47%
-97.39%
-99.99%
-99.96%
British American Tobacco P.l.c.
British American Tobacco P.l.c.
7.69%
21.64%
15.62%
7.14%
-3.98%
Altria Group Inc.
Altria Group Inc.
13.92%
24.3%
36.8%
28.23%
15.16%
Philip Morris International, Inc.
Philip Morris International, Inc.
-1.08%
30.45%
37.79%
45.0%
57.81%
Rlx Technology Inc
Rlx Technology Inc
12.5%
-6.74%
-20.0%
-63.78%
-84.81%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
22nd Century Group Inc
22nd Century Group Inc
0.01
NA
0.0
0.0
0.36
-0.23
NA
0.26
British American Tobacco P.l.c.
British American Tobacco P.l.c.
6.03
NA
3.15
4.55
-0.21
0.05
0.08
23.58
Altria Group Inc.
Altria Group Inc.
9.46
9.46
3.93
5.12
0.0
0.21
0.07
-2.04
Philip Morris International, Inc.
Philip Morris International, Inc.
20.83
20.83
1.62
6.49
0.0
0.13
0.04
-6.23
Rlx Technology Inc
Rlx Technology Inc
25.43
25.43
NA
0.69
0.04
-0.01
0.01
12.74
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
22nd Century Group Inc
22nd Century Group Inc
Sell
$4.6M
-99.96%
0.01
0.0%
British American Tobacco P.l.c.
British American Tobacco P.l.c.
Buy
$78.3B
-3.98%
6.03
-52.84%
Altria Group Inc.
Altria Group Inc.
Buy
$95.0B
15.16%
9.46
50.51%
Philip Morris International, Inc.
Philip Morris International, Inc.
Buy
$204.0B
57.81%
20.83
26.42%
Rlx Technology Inc
Rlx Technology Inc
Buy
$2.8B
-84.81%
25.43
34.75%

Insights on 22nd Century Group Inc

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 7.94M → 5.94M (in $), with an average decrease of 25.2% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -1.11M → -3.75M (in $), with an average decrease of 237.9% per quarter

  • Vs PM

    In the last 1 year, Philip Morris International, Inc. has given 38.6% return, outperforming this stock by 136.0%

  • Vs PM

    In the last 3 years, Philip Morris International, Inc. has given 45.0% return, outperforming this stock by 145.0%

Institutional Holdings

  • Geode Capital Management, LLC

    0.11%
  • Virtu Financial LLC

    0.09%
  • HRT FINANCIAL LLC

    0.07%
  • Vanguard Group Inc

    0.03%
  • Morgan Stanley - Brokerage Accounts

    0.03%
  • BlackRock Inc

    0.02%

Company Information

with the mission of reducing the harm caused by smoking, 22nd century is a plant biotechnology company whose proprietary technology allows for the levels of nicotine in the tobacco plant to be decreased or increased through genetic engineering and plant breeding. goodrich tobacco company and hercules pharmaceuticals are wholly-owned subsidiaries focusing on (i) premium cigarettes and potentially reduced risk tobacco products (with up to 97% less nicotine than conventional cigarettes), and (ii) the x-22 prescription smoking cessation aid in development. 22nd century's technology also allows the levels of cannabinoids to be decreased or increased in the cannabis plant.

Organization
22nd Century Group Inc
Employees
64
CEO
Mr. Lawrence D. Firestone
Industry
Miscellaneous

FAQs